Ascletis Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ascletis Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013149
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascletis Inc (Ascletis) is a healthcare company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of global partnering, clinical proof-of-concept, and research and development services of novel therapeutics for life-threatening diseases. Its research and development services comprise product indication, lead development, pre clinical studies and phase development services. Ascletis’s development pipelines comprise danoprevirs, PPI, ALN-VSP and others. The company offers discovery and development of important therapeutics with both small molecule and biologics approaches. It provides in-licensing, late-stage clinical development, and commercialization services. The company has its presence in the US and China. Ascletis is headquartered in Chapel Hill, North Carolina, the US.

Ascletis Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ascletis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ascletis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ascletis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ascletis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ascletis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ascletis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ascletis Pharma Raises USD100.7 Million in Series B Financing 10
Ascletis Raises USD35 Million in Venture Financing 11
Ascletis Raises US$50 Million In First Tranche Of Series A Financing 12
Partnerships 13
Roche Enters Into Agreement With Ascletis To Develop HCV Drug Danoprevir 13
Ascletis Enters Into Agreement With Minsheng Pharma For R&D 14
Licensing Agreements 15
Ascletis Pharma Enters into Licensing Agreement with Medivir for MIV-802 15
Ascletis Enters into Licensing Agreement with Presidio Pharma for PPI-668 16
Ascletis Enters Into Licensing Agreement With Janssen For TMC310911 17
Alnylam Pharma Enters Into Licensing Agreement With Ascletis Pharma (Hangzhou) To Develop ALN-VSP 18
Equity Offering 19
Ascletis Raises USD20 Million in Private Placement of Shares 19
Ascletis Inc – Key Competitors 20
Ascletis Inc – Key Employees 21
Ascletis Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Ascletis Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ascletis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ascletis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ascletis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ascletis Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ascletis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ascletis Pharma Raises USD100.7 Million in Series B Financing 10
Ascletis Raises USD35 Million in Venture Financing 11
Ascletis Raises US$50 Million In First Tranche Of Series A Financing 12
Roche Enters Into Agreement With Ascletis To Develop HCV Drug Danoprevir 13
Ascletis Enters Into Agreement With Minsheng Pharma For R&D 14
Ascletis Pharma Enters into Licensing Agreement with Medivir for MIV-802 15
Ascletis Enters into Licensing Agreement with Presidio Pharma for PPI-668 16
Ascletis Enters Into Licensing Agreement With Janssen For TMC310911 17
Alnylam Pharma Enters Into Licensing Agreement With Ascletis Pharma (Hangzhou) To Develop ALN-VSP 18
Ascletis Raises USD20 Million in Private Placement of Shares 19
Ascletis Inc, Key Competitors 20
Ascletis Inc, Key Employees 21
Ascletis Inc, Other Locations 22
Ascletis Inc, Subsidiaries 22

★海外企業調査レポート[Ascletis Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Folksam:企業のM&A・事業提携・投資動向
    Folksam - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Folksam Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Bank of the Philippine Islands:企業の戦略・SWOT・財務情報
    Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • McCormick & Company Incorporated:戦略・SWOT・企業財務分析
    McCormick & Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary McCormick & Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • John Keells Holdings PLC (JKH.N0000):企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務情報
    Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Ebara Corp (6361):企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • SAES Getters S.p.A. (SG):企業の財務・戦略的SWOT分析
    SAES Getters S.p.A. (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Middlesex Water Company (MSEX):企業の財務・戦略的SWOT分析
    Summary Middlesex Water Company (Middlesex Water) is a provider of water and wastewater management services. The company's services include water production, treatment and distribution, regulated and non-regulated water and wastewater utility services, working to promote economic development, and bu …
  • VLP Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary VLP Therapeutics LLC (VLP) is a biopharmaceutical company that develops therapeutic vaccines and next generation of targeted antibody agents to address global unmet medical needs. The company offers product such as vaccines for the treatment of cancer types such as breast, lung, prostate can …
  • Grifols SA (GRF):医療機器:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Tata Advanced Systems Ltd:企業の戦略・SWOT・財務情報
    Tata Advanced Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Tata Advanced Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Tervita Corp:企業の戦略・SWOT・財務情報
    Tervita Corp - Strategy, SWOT and Corporate Finance Report Summary Tervita Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ornua Co-operative Ltd:企業の戦略・SWOT・財務分析
    Ornua Co-operative Ltd - Strategy, SWOT and Corporate Finance Report Summary Ornua Co-operative Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lam Research Corporation:企業の戦略・SWOT・財務分析
    Lam Research Corporation - Strategy, SWOT and Corporate Finance Report Summary Lam Research Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Allscripts Healthcare Solutions Inc (MDRX):企業の財務・戦略的SWOT分析
    Allscripts Healthcare Solutions Inc (MDRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Medical Developments International Ltd (MVP)-製薬・医療分野:企業M&A・提携分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company’s products include penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products which inclu …
  • Elmet Technologies, Inc.:企業の戦略・SWOT・財務情報
    Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Orascom Development Egypt Sae
    Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report Summary Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆